134 related articles for article (PubMed ID: 22621723)
1. Severe aortic insufficiency secondary to 5L Impella device placement.
Chandola R; Cusimano R; Osten M; Horlick E
J Card Surg; 2012 May; 27(3):400-2. PubMed ID: 22621723
[TBL] [Abstract][Full Text] [Related]
2. Postcardiac transplant transcatheter core valve implantation for aortic insufficiency secondary to Impella device placement.
Chandola R; Cusimano R; Osten M; Horlick E
Ann Thorac Surg; 2012 Jun; 93(6):e155-7. PubMed ID: 22632535
[TBL] [Abstract][Full Text] [Related]
3. Acquired aortic cusp fusion after chronic left ventricular assist device support.
Banchs JE; Dawn B; Abdel-Latif A; Qureshi A; Agrawal N; Bouvette M; Stoddard MF
J Am Soc Echocardiogr; 2006 Nov; 19(11):1401.e1-3. PubMed ID: 17098144
[TBL] [Abstract][Full Text] [Related]
4. Aortic insufficiency associated with Impella that required surgical intervention upon implantation of the durable left ventricular assist device.
Oishi H; Kondo T; Fujimoto K; Mutsuga M; Morimoto R; Hirano KI; Sawamura A; Kazama S; Kimura Y; Shibata N; Kato H; Arao Y; Kuwayama T; Yamaguchi S; Hiraiwa H; Okumura T; Usui A; Murohara T
J Artif Organs; 2020 Dec; 23(4):378-382. PubMed ID: 32562105
[TBL] [Abstract][Full Text] [Related]
5. Aortic regurgitation during systolic-phase accompanied by mitral regurgitation in patients with continuous-flow left ventricular assist device.
Kato TS; Maurer MS; Sera F; Homma S; Mancini D
Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):1022. PubMed ID: 23592722
[No Abstract] [Full Text] [Related]
6. Trans-catheter closure of the native aortic valve with an Amplatzer Occluder to treat progressive aortic regurgitation after implantation of a left-ventricular assist device.
Grohmann J; Blanke P; Benk C; Schlensak C
Eur J Cardiothorac Surg; 2011 Jun; 39(6):e181-3. PubMed ID: 21377889
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular assist device-related systolic aortic regurgitation.
Martina J; de Jonge N; Sukkel E; Lahpor J
Circulation; 2011 Jul; 124(4):487-8. PubMed ID: 21788601
[No Abstract] [Full Text] [Related]
8. Percutaneous SAPIEN S3 Transcatheter Valve Implantation for Post-Left Ventricular Assist Device Aortic Regurgitation.
Kornberger A; Beiras-Fernandez A; Fichtlscherer S; Assmus B; Moritz A; Stock UA
Ann Thorac Surg; 2015 Oct; 100(4):e67-9. PubMed ID: 26434481
[TBL] [Abstract][Full Text] [Related]
9. Pathological Evidence of Native Aortic Valve Injury After Impella Support.
Higashi H; Nishimura T; Aono J; Sakaue T; Kurata M; Izutani H; Yamaguchi O
Circ Heart Fail; 2021 Feb; 14(2):e007571. PubMed ID: 33478243
[No Abstract] [Full Text] [Related]
10. Percutaneous closure of the aortic valve as a bridge to heart transplantation to treat severe aortic insufficiency after ventricular assist device.
Sauer AJ; Davidson CJ; McGee EC
Catheter Cardiovasc Interv; 2015 Aug; 86(2):E103-6. PubMed ID: 24975484
[TBL] [Abstract][Full Text] [Related]
11. Aortic Valve Insufficiency as a Late Complication After Impella Device Implantation.
Olsthoorn JR; Goossens EAC; Lam K; Tonino PAL; van Dantzig JM
JACC Cardiovasc Interv; 2022 Apr; 15(8):e91-e93. PubMed ID: 35367172
[No Abstract] [Full Text] [Related]
12. Persistent aortic insufficiency secondary to Impella device implantation.
Sharma S; Briasoulis A; Afonso L
Int J Cardiol; 2014 Sep; 176(1):e9-10. PubMed ID: 25034803
[No Abstract] [Full Text] [Related]
13. Prediction of the Development of Aortic Regurgitation After Impella Left Ventricular Assist Device Support.
Imamura T
J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2550-2551. PubMed ID: 32475779
[No Abstract] [Full Text] [Related]
14. Color Doppler Artifact Masking Iatrogenic Aortic Valve Injury Related to an Impella Device.
Hong E; Naseem T
J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1584-1587. PubMed ID: 30467028
[TBL] [Abstract][Full Text] [Related]
15. Is a Bioprosthetic Valve in the Aortic Position Desirable with a Continuous Flow LVAD?
Doi A; Marasco SF; McGiffin DC
J Card Surg; 2015 May; 30(5):466-8. PubMed ID: 25807875
[TBL] [Abstract][Full Text] [Related]
16. Mini right thoracotomy as an approach to aortic valve closure in an assist device patient.
Doersch KM; Sareyyupoglu B
ASAIO J; 2015; 61(1):96-7. PubMed ID: 25303797
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Severity of Aortic Regurgitation Due to a Percutaneous Left Ventricular Assist Device (Impella 5.0): A Retrospective Observational Study.
Hotta N; Tsukinaga A; Yoshitani K; Fukushima S; Ohnishi Y
J Cardiothorac Vasc Anesth; 2023 Jan; 37(1):23-30. PubMed ID: 36372720
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous transcatheter closure of the aortic valve to treat cardiogenic shock in a left ventricular assist device patient with severe aortic insufficiency.
Russo MJ; Freed BH; Jeevanandam V; Hashmi M; Paul JD; Anderson A; Lang RM; Shah AP
Ann Thorac Surg; 2012 Sep; 94(3):985-8. PubMed ID: 22916753
[TBL] [Abstract][Full Text] [Related]
19. Acute Mitral Regurgitation After Removal of an Impella Device.
Bhatia N; Richardson TD; Coffin ST; Keebler ME
Am J Cardiol; 2017 Apr; 119(8):1290-1291. PubMed ID: 28196639
[TBL] [Abstract][Full Text] [Related]
20. Direct aortic transcatheter aortic valve implantation for pure aortic valve regurgitation after implantation of a left ventricular assist device.
Krause R; Metz D; Bushnaq H
J Thorac Cardiovasc Surg; 2014 Apr; 147(4):e38-41. PubMed ID: 24495901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
